Skip to main content
IMMX
NASDAQ Life Sciences

Immix Biopharma Posts $29.44M Net Loss, $(0.89) EPS in 2025 10-K

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$9.05
Mkt Cap
$471.83M
52W Low
$1.34
52W High
$11.61
52W Position info
575% above low
Off High info
22% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

IMMX has more than doubled off its 52-week low of $1.34.

Summary

Immix Biopharma reported a net loss of $29.44 million and an EPS of $(0.89) for fiscal year 2025, as detailed in its 10-K filing. These results reflect significant operating expenses, primarily driven by elevated clinical development activity for its lead CAR-T candidate, NXC-201, and increased R&D spending. The company also noted completing multiple equity raises and ATM sales in 2025 to fund these operations. For a development-stage biopharma, these losses indicate a substantial cash burn rate, which is a critical factor for investors. Traders will monitor the company's cash position, future financing needs (especially in light of the $750M shelf registration filed in January), and progress in clinical trials for NXC-201 as key catalysts.

At the time of this announcement, IMMX was trading at $9.05 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $471.8M. The 52-week trading range was $1.34 to $11.61. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

IMMX - Latest Insights

IMMX
Nov 12, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.07
Real-time Price: $7.84 info
Change: -$0.230 (-3%) info
Market Cap: $649.959M info
IMMX
Nov 12, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $8.07
Real-time Price: $7.84 info
Change: -$0.230 (-3%) info
Market Cap: $649.959M info
IMMX
Sep 30, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.40
Real-time Price: $7.84 info
Change: -$2.56 (-25%) info
Market Cap: $649.959M info
IMMX
Sep 29, 2026, 7:22 AM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $12.15
Real-time Price: $7.84 info
Change: -$4.31 (-35%) info
Market Cap: $649.959M info
IMMX
Sep 29, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.58
Real-time Price: $7.84 info
Change: -$3.74 (-32%) info
Market Cap: $649.959M info